CAPON Is a Critical Protein in Synaptic Molecular Networks in the Prefrontal Cortex of Mood Disorder Patients and Contributes to Depression-Like Behavior in a Mouse Model.

Aberrant regulation and activity of synaptic proteins may cause synaptic pathology in the prefrontal cortex (PFC) of mood disorder patients. Carboxy-terminal PDZ ligand of NOS1 (CAPON) is a critical scaffold protein linked to synaptic proteins like nitric oxide synthase 1, synapsins. We hypothesized that CAPON is altered together with its interacting synaptic proteins in the PFC in mood disorder patients and may contribute to depression-like behaviors in mice subjected to chronic unpredictable mild stress (CUMS). Here, we found that CAPON-immunoreactivity (ir) was significantly increased in the dorsolateral PFC (DLPFC) and anterior cingulate cortex in major depressive disorder (MDD), which was accompanied by an upregulation of spinophilin-ir and a downregulation of synapsin-ir. The increases in CAPON and spinophilin and the decrease in synapsin in the DLPFC of MDD patients were also seen in the PFC of CUMS mice. CAPON-ir positively correlated with spinophilin-ir (but not with synapsin-ir) in mood disorder patients. CAPON colocalized with spinophilin in the DLPFC of MDD patients and interacted with spinophilin in human brain. Viral-mediated CAPON downregulation in the medial PFC notably reversed the depression-like behaviors in the CUMS mice. These data suggest that CAPON may contribute to aspects of depressive behavior, possibly as an interacting protein for spinophilin in the PFC.

[1]  Qingming Meng,et al.  The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway. , 2018, Cancer letters.

[2]  B. Morentin,et al.  Characterisation of spinophilin immunoreactivity in postmortem human brain homogenates , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  Liping Chen,et al.  Age-dependent differential regulation of anxiety- and depression-related behaviors by neurabin and spinophilin , 2017, PloS one.

[4]  R. Sweet,et al.  Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease , 2017, Neurobiology of Aging.

[5]  Q. Shi,et al.  Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway , 2017, Scientific Reports.

[6]  Hans-Ulrich Klein,et al.  Diurnal and seasonal molecular rhythms in human neocortex and their relation to Alzheimer's disease , 2017, Nature Communications.

[7]  R. Verwer,et al.  Prefrontal changes in the glutamate-glutamine cycle and neuronal/glial glutamate transporters in depression with and without suicide. , 2016, Journal of psychiatric research.

[8]  Lei Jin,et al.  Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway , 2016, International journal of molecular sciences.

[9]  L. Callado,et al.  P.3.e.001 Spinophilin expression in postmortem prefrontal cortex of subjects with schizophrenia: effect of antipsychotic treatment , 2016, European Neuropsychopharmacology.

[10]  Shangfeng Gao,et al.  Research progress in NOS1AP in neurological and psychiatric diseases , 2016, Brain Research Bulletin.

[11]  S. L. la Fleur,et al.  Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients. , 2016, The Journal of clinical endocrinology and metabolism.

[12]  J. Harro,et al.  Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology , 2016, European Neuropsychopharmacology.

[13]  B. Firestein,et al.  Overexpression of Isoforms of Nitric Oxide Synthase 1 Adaptor Protein, Encoded by a Risk Gene for Schizophrenia, Alters Actin Dynamics and Synaptic Function , 2016, Front. Cell. Neurosci..

[14]  J. Nyengaard,et al.  Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat hippocampus , 2016, European Neuropsychopharmacology.

[15]  Xin-ming Ma,et al.  Dendritic Spines in Depression: What We Learned from Animal Models , 2016, Neural plasticity.

[16]  C. P. Morris,et al.  Association of NOS1AP variants and depression phenotypes in schizophrenia. , 2015, Journal of affective disorders.

[17]  Li-Tao Yi,et al.  Fluoxetine regulates mTOR signalling in a region-dependent manner in depression-like mice , 2015, Scientific Reports.

[18]  B. Turetsky,et al.  Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia , 2015, Schizophrenia Research.

[19]  A. Sampson,et al.  Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia , 2015, Biological Psychiatry.

[20]  D. Swaab,et al.  Different stress-related gene expression in depression and suicide. , 2015, Journal of psychiatric research.

[21]  R. Duman,et al.  Spine synapse remodeling in the pathophysiology and treatment of depression , 2015, Neuroscience Letters.

[22]  G. Wegener,et al.  Potential roles for Homer1 and Spinophilin in the preventive effect of electroconvulsive seizures on stress-induced CA3c dendritic retraction in the hippocampus , 2015, European Neuropsychopharmacology.

[23]  Young Hye Kim,et al.  A 3D human neural cell culture system for modeling Alzheimer's disease , 2015, Nature Protocols.

[24]  B. Firestein,et al.  Nitric Oxide Synthase 1 Adaptor Protein, a Protein Implicated in Schizophrenia, Controls Radial Migration of Cortical Neurons , 2015, Biological Psychiatry.

[25]  Michael J Courtney,et al.  Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models , 2015, The Journal of Neuroscience.

[26]  F. Holsboer,et al.  A role for synapsin in FKBP51 modulation of stress responsiveness: Convergent evidence from animal and human studies , 2015, Psychoneuroendocrinology.

[27]  J. Coyle,et al.  Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. , 2014, JAMA psychiatry.

[28]  A. Bao,et al.  Nitric oxide synthase and nitric oxide alterations in chronically stressed rats: A model for nitric oxide in major depressive disorder , 2014, Psychoneuroendocrinology.

[29]  Li-Li Li,et al.  Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling , 2014, Front. Cell. Neurosci..

[30]  W. Lu,et al.  CAPON-nNOS coupling can serve as a target for developing new anxiolytics , 2014, Nature Medicine.

[31]  J. Pruessner,et al.  Neuropathology of stress , 2013, Acta Neuropathologica.

[32]  D. Swaab,et al.  Decreased NOS1 expression in the anterior cingulate cortex in depression. , 2013, Cerebral cortex.

[33]  P. Licznerski,et al.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression , 2013, Neuroscience.

[34]  M. Tremblay,et al.  The New Small-Molecule Mixed-Lineage Kinase 3 Inhibitor URMC-099 Is Neuroprotective and Anti-Inflammatory in Models of Human Immunodeficiency Virus-Associated Neurocognitive Disorders , 2013, The Journal of Neuroscience.

[35]  D. Swaab,et al.  Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients , 2013, Psychoneuroendocrinology.

[36]  C. P. Morris,et al.  NOS1AP is associated with increased severity of PTSD and depression in untreated combat veterans. , 2013, Journal of affective disorders.

[37]  A. Kalsbeek,et al.  Melanocortin 4 receptor distribution in the human hypothalamus. , 2013, European journal of endocrinology.

[38]  M. Doucet,et al.  Small-Molecule Inhibitors at the PSD-95/nNOS Interface have Antidepressant-Like Properties in Mice , 2013, Neuropsychopharmacology.

[39]  G. Rajkowska,et al.  Decreased Expression of Synapse-Related Genes and Loss of Synapses in Major Depressive Disorder , 2012, Nature Medicine.

[40]  G. Wegener,et al.  Wistar rats subjected to chronic restraint stress display increased hippocampal spine density paralleled by increased expression levels of synaptic scaffolding proteins , 2012, Stress.

[41]  Adem Can,et al.  The mouse forced swim test. , 2011, Journal of visualized experiments : JoVE.

[42]  Li-Juan Zhu,et al.  Hippocampal Neuronal Nitric Oxide Synthase Mediates the Stress-Related Depressive Behaviors of Glucocorticoids by Downregulating Glucocorticoid Receptor , 2011, The Journal of Neuroscience.

[43]  A. Bao,et al.  Corticotropin-Releasing Hormone, Glutamate, and γ-Aminobutyric Acid in Depression , 2011, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[44]  S. Buyske,et al.  NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia , 2010, Schizophrenia Research.

[45]  T. Sharp,et al.  Regulation of markers of synaptic function in mouse models of depression: chronic mild stress and decreased expression of VGLUT1 , 2010, Journal of neurochemistry.

[46]  F. Benfenati,et al.  The synapsins: Key actors of synapse function and plasticity , 2010, Progress in Neurobiology.

[47]  Chun Cheng,et al.  Inhibition of nitric oxide-induced nuclear localization of CAPON by NMDA receptor antagonist in cultured rat primary astrocytes , 2010, Neurochemistry International.

[48]  M. Pompili,et al.  Anatomical and functional correlates in major depressive disorder: The contribution of neuroimaging studies , 2010 .

[49]  D. Tabb,et al.  Identification and Validation of Novel Spinophilin-associated Proteins in Rodent Striatum Using an Enhanced ex Vivo Shotgun Proteomics Approach* , 2010, Molecular & Cellular Proteomics.

[50]  F. J. Monje,et al.  Rodent models in depression research: Classical strategies and new directions , 2010, Annals of medicine.

[51]  B. Firestein,et al.  NOS1AP Regulates Dendrite Patterning of Hippocampal Neurons through a Carboxypeptidase E-Mediated Pathway , 2009, The Journal of Neuroscience.

[52]  F. Benfenati,et al.  Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment , 2008, Journal of Cell Science.

[53]  M. Furey,et al.  Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression , 2008, Brain Structure and Function.

[54]  Chun Cheng,et al.  Spatiotemporal Expression of Dexras1 After Spinal Cord Transection in Rats , 2008, Cellular and Molecular Neurobiology.

[55]  Bin Wang,et al.  Neuronal nitric oxide synthase contributes to chronic stress‐induced depression by suppressing hippocampal neurogenesis , 2007, Journal of neurochemistry.

[56]  Ho Tak Lau,et al.  Micro-dissection of rat brain for RNA or protein extraction from specific brain region. , 2007, Journal of visualized experiments : JoVE.

[57]  R. Vertes,et al.  Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat , 2007, Brain Structure and Function.

[58]  G. Rajkowska,et al.  Gliogenesis and glial pathology in depression. , 2007, CNS & neurological disorders drug targets.

[59]  P. Maycox,et al.  Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons , 2006, Molecular and Cellular Neuroscience.

[60]  Bin Xu,et al.  Increased Expression in Dorsolateral Prefrontal Cortex of CAPON in Schizophrenia and Bipolar Disorder , 2005, PLoS medicine.

[61]  A. Bassett,et al.  Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. , 2004, American journal of human genetics.

[62]  M. León‐Olea,et al.  Nitric oxide synthase inhibition during synaptic maturation decreases synapsin I immunoreactivity in rat brain. , 2004, Nitric oxide : biology and chemistry.

[63]  P. Greengard,et al.  Subcellular distribution of spinophilin immunolabeling in primate prefrontal cortex: Localization to and within dendritic spines , 2004, The Journal of comparative neurology.

[64]  P. Goldman-Rakic,et al.  Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia. , 2003, Archives of general psychiatry.

[65]  Sabine Landau,et al.  Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. , 2002, Cerebral cortex.

[66]  A. Czernik,et al.  Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Kerwin,et al.  Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. , 2001, Archives of general psychiatry.

[68]  L. Selemon,et al.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder , 2001, Biological Psychiatry.

[69]  P. Greengard,et al.  Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex , 2001, Biological Psychiatry.

[70]  P. Greengard,et al.  Spinophilin regulates the formation and function of dendritic spines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[71]  G. Rosoklija,et al.  Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. , 2000, Archives of general psychiatry.

[72]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[73]  W. Kamphorst,et al.  Comparison of β-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer’s disease patients: amorphic plaques and cytoskeletal changes occur independently , 1998, Acta Neuropathologica.

[74]  S. Snyder,et al.  CAPON: A Protein Associated with Neuronal Nitric Oxide Synthase that Regulates Its Interactions with PSD95 , 1998, Neuron.

[75]  P. Greengard,et al.  Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[76]  D. Swaab,et al.  The art of matching brain tissue from patients and controls for postmortem research. , 2018, Handbook of clinical neurology.

[77]  D. Swaab,et al.  Abnormal retinoid and TrkB signaling in the prefrontal cortex in mood disorders. , 2015, Cerebral cortex.

[78]  C. Portugal,et al.  Nitric oxide in the nervous system: biochemical, developmental, and neurobiological aspects. , 2014, Vitamins and hormones.

[79]  D. Swaab,et al.  Neurotransmitters and neuropeptides in depression. , 2012, Handbook of clinical neurology.

[80]  Wei Zhang,et al.  Reduced Dendritic Spine Density in Auditory Cortex of Subjects with Schizophrenia , 2009, Neuropsychopharmacology.

[81]  E. Batschelet Circular statistics in biology , 1981 .